Could donor islet cells free brittle diabetics from insulin shots?
NCT ID NCT01630850
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether transplanting insulin-producing islet cells from deceased donors can help people with brittle type 1 diabetes achieve safer blood sugar control without insulin shots. Up to 20 adults aged 18–70 with long-standing type 1 diabetes will receive the cells through a vein. The main goal is to see if this approach can keep HbA1c below 7% and prevent severe low blood sugar episodes for a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Can a peptide tame type 1 diabetes?
- Can a tiny implant track glucose, ketones, and lactate in diabetes?
- Wearable sensor could unmask hidden blood sugar chaos in stomach paralysis
- A smarter insulin that aims for the liver could curb dangerous nighttime dips
- Smart insulin pump may boost brain and body health in older adults with diabetes